According to MiMedx Group's latest financial reports the company has $48.48 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $82 M | 24.34% |
2022-12-31 | $65.95 M | -24.27% |
2021-12-31 | $87.08 M | -9.11% |
2020-12-31 | $95.81 M | 38.72% |
2019-12-31 | $69.06 M | 53.09% |
2018-12-31 | $45.11 M | 64.21% |
2017-12-31 | $27.47 M | -20.11% |
2016-12-31 | $34.39 M | 9.23% |
2015-12-31 | $31.48 M | -39.83% |
2014-12-31 | $52.33 M | 18.73% |
2013-12-31 | $44.07 M | 552.57% |
2012-12-31 | $6.75 M | 64.25% |
2011-12-31 | $4.11 M | 206.68% |
2010-12-31 | $1.34 M | -49.47% |
2009-12-31 | $2.65 M | |
2009-03-31 | $0.03 M | -99.48% |
2008-03-31 | $6.74 M | |
2007-12-31 | $0 M | -97.1% |
2006-12-31 | $0 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Medtronic MDT | $8.32 B | 17,061.30% | ๐ฎ๐ช Ireland |
Teleflex TFX | $0.22 B | 359.60% | ๐บ๐ธ USA |
Steris STE | $0.19 B | 303.38% | ๐ฎ๐ช Ireland |
NuVasive NUVA | $80.71 M | 66.47% | ๐บ๐ธ USA |
Hill-Rom HRC | N/A | N/A | ๐บ๐ธ USA |
CryoLife CRY | N/A | N/A | ๐บ๐ธ USA |